Clinical trials are what's between a discovery and a cure. The way they're designed today belongs to the era of the static document, scattered decisions, and absent precedent. We treat it as a living system instead.
Built for the teams
designing trials.
Altrovia is in private deployment with a small set of organizations across four segments. Each one designs trials under different constraints. Each one gets a version of Altrovia shaped to the work they actually do.

Enterprise pharma.
Sponsors running parallel programs across therapeutic areas. Where every program inherits what the last one learned.

Emerging biotech.
Clinical-stage biotechs designing the trial that defines the company. Submission-ready trial design, sized to the team you have.

Contract research organizations.
CROs whose scientific depth shapes every sponsor conversation. Sponsor-grade thinking, made visible and defensible.

Public sector.
Academic medical centers, government research bodies, and publicly-funded consortia. IITs at sponsor standard.